Cargando…

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment

Detalles Bibliográficos
Autores principales:	Yurttutan, Sadık, Gullu, Utku Ufuk, Ipek, Sevcan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Ce - Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889409/ https://www.ncbi.nlm.nih.gov/pubmed/33598871 http://dx.doi.org/10.1007/s11739-021-02663-6

Ejemplares similares

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Clinical and laboratory findings of multisystem inflammatory syndrome in children (MIS-C) below age 1
por: Yurttutan, Sadık, et al.
Publicado: (2021)

MIS-C with diarrhea complaint and acute kidney injury: A pediatric COVID-19 patient
por: İpek, Sevcan, et al.
Publicado: (2021)

Predictive value of cardiac markers in the prognosis of COVID-19 in children
por: Güllü, Ufuk Utku, et al.
Publicado: (2021)

Is N95 face mask linked to dizziness and headache?
por: İpek, Sevcan, et al.
Publicado: (2021)

Evaluation of Pulmonary Functions After Discharge in Pediatric Patients with COVID-19: A Prospective Study
por: Ipek, Sevcan, et al.
Publicado: (2022)

Nosocomial Infections in Non-COVID-19 Pediatric Patients Prior to and During the Pandemic in a Pediatric Intensive Care Unit
por: İpek, Sevcan, et al.
Publicado: (2022)

Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids: A retrospective cohort study
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Oral health experiences of Turkish children with acute rheumatic fever or rheumatic heart disease
por: Sogukpinar Onsuren, Aslı, et al.
Publicado: (2022)

The effect of full blood count and cardiac biomarkers on prognosis in carbon monoxide poisoning in children
por: İpek, Sevcan, et al.
Publicado: (2022)

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation
por: Potere, Nicola, et al.
Publicado: (2020)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series
por: Clark, Kristina E N, et al.
Publicado: (2020)

Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience: reply
por: De Monte, Amato, et al.
Publicado: (2021)

The need for a correct oxygen-ozone autohemotherapy (O(3)-AHT) in patients with mild to moderate COVID-19 pneumonia
por: Chirumbolo, Salvatore, et al.
Publicado: (2021)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011)

Anakinra/tocilizumab: Primary biliary cholangitis: case report
Publicado: (2021)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

High-dose steroids for the treatment of severe COVID-19: comment
por: Tanaka, Shuichi, et al.
Publicado: (2021)

Lung ultrasound presentation of covid-19 patients: phenotypes and correlations—comment
por: Nekludova, Galina, et al.
Publicado: (2021)

Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment
por: Magon, Arianna, et al.
Publicado: (2021)

“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Clinical and Cytokine Profile of Children With COVID-19: A Report From Turkey
por: Dalkıran, Tahir, et al.
Publicado: (2023)

Orthostatic hypotension among elderly patients in Italian internal medicine wards: an observational study—comment
por: Bolek, Hatice, et al.
Publicado: (2020)

Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment
por: Rossio, Raffaella, et al.
Publicado: (2021)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Allione, Attilio, et al.
Publicado: (2020)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Roncon, Loris, et al.
Publicado: (2020)

2648. Taming the Cytokine Storm: Baricitinib versus Tocilizumab for COVID-19 Hyperinflammation
por: Radziszewski, Skyler, et al.
Publicado: (2023)

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
por: Bandera, Alessandra, et al.
Publicado: (2021)

Bronchoalveolar lavage findings in severe COVID-19 pneumonia
por: Voiriot, Guillaume, et al.
Publicado: (2020)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit
por: Vargas, Nicolas, et al.
Publicado: (2022)

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment
por: Rajput, Dinesh Vijay
Publicado: (2020)

Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2021)

Delirium in COVID‑19 pneumonia: looking inside the geriatric unit—reply
por: Callea, Antonio, et al.
Publicado: (2022)

Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study
por: KÜÇÜKŞAHİN, Orhan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i1sqmlkcenp9ua93bog7emokat